(Q54320713)

English

Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study.

scientific article published in December 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

cervical intraepithelial neoplasia

1 reference

based on heuristic

inferred from title

author name string

T D de Gruijl

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

H J Bontkes

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

J M Walboomers

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

M J Stukart

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

A A Robbesom

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

B M von Blomberg-van der Flier

6

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

P Herbrink

7

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

A J Remmink

8

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

R H Verheijen

9

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

T J Helmerhorst

10

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

C J Meijer

11

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

R J Scheper

12

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

language of work or name

0 references

publication date

1 December 1996

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

68

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

6

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

731-738

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

Serologic response in human papillomavirus-associated invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

Follow-up of antibody responses to human papillomavirus type 16 E7 in patients treated for cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

Disappearance of antibodies to HPV 16 E7 after treatment for cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

IgG2 deficiency associated with defects in production of interferon-gamma; comparison with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961211%2968%3A6%3C731%3A%3AAID-IJC7%3E3.0.CO%3B2-4

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(19961211)68:6<731::AID-IJC7>3.0.CO;2-4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/8980175

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54320713&oldid=1499435482"